SeqLL Inc.
Index- P/E- EPS (ttm)-0.34 Insider Own22.20% Shs Outstand11.89M Perf Week-2.10%
Market Cap5.80M Forward P/E- EPS next Y-0.64 Insider Trans0.28% Shs Float7.52M Perf Month-36.61%
Income-4.10M PEG- EPS next Q- Inst Own0.20% Short Float / Ratio1.47% / 0.04 Perf Quarter42.81%
Sales0.11M P/S51.05 EPS this Y32.90% Inst Trans262.50% Short Interest0.11M Perf Half Y-46.67%
Book/sh0.37 P/B1.08 EPS next Y-21.90% ROA-41.90% Target Price- Perf Year-67.48%
Cash/sh0.43 P/C0.94 EPS next 5Y- ROE-69.50% 52W Range0.23 - 2.40 Perf YTD37.60%
Dividend- P/FCF- EPS past 5Y-11.70% ROI- 52W High-83.33% Beta-
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin- 52W Low73.76% ATR0.08
Employees7 Current Ratio5.40 Sales Q/Q- Oper. Margin- RSI (14)40.22 Volatility11.72% 11.79%
OptionableNo Debt/Eq0.32 EPS Q/Q11.20% Profit Margin- Rel Volume0.03 Prev Close0.42
ShortableYes LT Debt/Eq0.32 Earnings- Payout- Avg Volume3.15M Price0.40
Recom2.00 SMA20-12.20% SMA50-35.03% SMA200-40.25% Volume87,321 Change-4.76%
Mar-17-23 08:30AM
Feb-22-23 06:00AM
Feb-15-23 04:00PM
Feb-13-23 08:30AM
Feb-10-23 09:21AM
07:30AM Loading…
Feb-07-23 07:30AM
Dec-22-22 04:00PM
Dec-13-22 09:25AM
Nov-11-22 06:07AM
Nov-09-22 10:08PM
Sep-13-22 11:56AM
Sep-12-22 08:00AM
Sep-06-22 08:01AM
Jun-24-22 04:05PM
Jun-13-22 08:00AM
08:00AM Loading…
May-13-22 08:00AM
Mar-30-22 05:06PM
Mar-24-22 04:05PM
Mar-21-22 04:15PM
Sep-29-21 06:04PM
Sep-27-21 08:00AM
Sep-23-21 02:49PM
Sep-10-21 12:19PM
Aug-31-21 03:17PM
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miscoll Douglas PatrickDirectorDec 19Buy0.331,500495103,736Dec 20 12:36 PM
Miscoll Douglas PatrickDirectorDec 16Buy0.351,500525103,736Dec 20 12:36 PM
JONES DANIEL ROBERTChief Executive OfficerDec 09Buy0.395,7332,2362,565,733Dec 13 03:36 PM
Miscoll Douglas PatrickDirectorSep 27Buy0.771,000774100,736Sep 28 11:05 AM
JONES DANIEL ROBERTChief Executive OfficerSep 26Buy0.795,0003,9472,560,000Sep 28 04:09 PM
Miscoll Douglas PatrickDirectorSep 26Buy0.75850638100,736Sep 28 11:05 AM
Miscoll Douglas PatrickDirectorSep 23Buy0.7615011498,886Sep 26 05:40 PM
Miscoll Douglas PatrickDirectorSep 22Buy0.792,4001,89698,886Sep 26 05:40 PM
Miscoll Douglas PatrickDirectorSep 02Buy0.881,00087596,316Sep 06 04:15 PM
Miscoll Douglas PatrickDirectorSep 01Buy0.892,6872,39196,316Sep 06 04:15 PM
Miscoll Douglas PatrickDirectorSep 01Buy0.901,10098796,316Sep 06 04:15 PM
Miscoll Douglas PatrickDirectorAug 31Buy0.9431329496,316Sep 06 04:15 PM
JONES DANIEL ROBERTChief Executive OfficerAug 26Buy0.996,8766,7862,555,000Aug 29 03:08 PM
JONES DANIEL ROBERTChief Executive OfficerAug 19Buy1.001,9901,9852,548,124Aug 23 11:06 AM
JONES DANIEL ROBERTChief Executive OfficerAug 18Buy1.005,0104,9892,551,144Aug 19 01:47 PM
PFEFFER DAVIDDirectorAug 17Buy1.0120,00020,16336,216Aug 19 01:51 PM
Milos Patrice M.DirectorAug 17Buy1.0110,00010,08837,027Aug 19 01:50 PM
JONES DANIEL ROBERTChief Executive OfficerAug 17Buy1.101,0001,0992,546,134Aug 19 01:47 PM